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Introduction: Microvascular reactivity is decreased in patients with septic shock; this is associated with worse
clinical outcomes. The objectives of the present study were to investigate microvascular reactivity in cardiac surgery
patients and to assess any association with clinical outcomes.
Methods: We retrospectively analyzed a prospectively collected registry. In total, 254 consecutive adult patients
undergoing cardiac and thoracic aortic surgeries from January 2013 through May 2014 were analyzed. We
performed a vascular occlusion test (VOT) by using near-infrared spectroscopy to measure microvascular reactivity.
VOT was performed three times per patient: prior to the induction of anesthesia, at the end of surgery, and on
postoperative day 1. The primary endpoint was a composite of major adverse complications, including death,
myocardial infarction, acute kidney injury, acute respiratory distress syndrome, and persistent cardiogenic shock.
Results: VOT recovery slope decreased during the surgery. VOT recovery slope on postoperative day 1 was
significantly lower in patients with composite complications than those without (3.1 ± 1.6 versus 4.0 ± 1.5
%/s, P = 0.001), although conventional hemodynamic values, such as cardiac output and blood pressure, did
not differ between the groups. On multivariable regression and linear analyses, low VOT recovery slope on
postoperative day 1 was associated with increases of composite complications (odds ratio 0.742; 95 %
confidence interval (CI) 0.584 to 0.943; P = 0.015) and hospital length of stay (regression coefficient (B) −1.276;
95 % CI −2.440 to −0.112; P = 0.032).
Conclusion: Microvascular reactivity largely recovered on postoperative day 1 in the patients without
composite complications, but this restoration was attenuated in patients with composite complications.
Trial registration: ClinicalTrials.gov NCT01713192. Registered 22 October 2012.Introduction
Tissue hypoperfusion is one of the earliest warning signs
in the critically ill [1]. It is considered a predictor of organ
ischemia and postoperative clinical outcomes [2–4]. It is
known that tissue hypoperfusion can occur with normal
or even supranormal cardiac output due to impaired
microcirculation [5]. The microcirculation is decreased in
patients with sepsis [2], patients with heart failure [6], and
critically ill patients [7]. Also, microcirculation is de-
creased in cardiac surgery patients, regardless of whether
cardiopulmonary bypass (CPB) was used [8].* Correspondence: jeonyunseok@gmail.com
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(http://creativecommons.org/publicdomain/zeThe vascular occlusion test (VOT) is a provocative test of
the microcirculation, which uses the dynamic response of
tissue oxygen saturation (StO2) to transient limb ischemia
and reperfusion. StO2 is measured by near-infrared spec-
troscopy (NIRS), which is a real-time non-invasive indicator
that reflects the ratio of oxygenated hemoglobin to total
hemoglobin in the tissue. StO2 provides information about
local tissue oxygenation and the state of the tissue microcir-
culation [9]. The recovery slope of StO2 during the VOT is
used as a measure of microvascular reactivity because it re-
flects post-ischemic reperfusion and hyperemia [10, 11].
Previous studies have reported that microvascular
reactivity is related to worse clinical outcomes in pa-
tients with sepsis [10, 12]. However, there are few data
about microvascular reactivity during the perioperativedistributed under the terms of the Creative Commons Attribution 4.0
.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
ive appropriate credit to the original author(s) and the source, provide a link to
changes were made. The Creative Commons Public Domain Dedication waiver
ro/1.0/) applies to the data made available in this article, unless otherwise stated.
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the strongest inducers of inflammatory reactions [13] and
in certain respects displays similarities with patients with
sepsis. Thus, we hypothesized that decreased microvascular
reactivity, measured by recovery slope, would be associated
with worse clinical outcomes in cardiac surgery patients.
The aims of the study were to investigate microvascular
reactivity in cardiac surgery patients and to assess any asso-
ciation with clinical outcomes.Methods
Patients
This was a retrospective analysis of a prospectively col-
lected registry to assess microvascular reactivity in pa-
tients undergoing cardiac surgery. This study used data
from the heart surgery registry at Seoul National University
Hospital. It was approved by the institutional review
board of Seoul National University Hospital, Seoul,
Korea (institutional review board #1207-111-419) and
was conducted in accordance with the Declaration of
Helsinki. Written informed consent was obtained from
each participant, and the trial was registered at Clinical-
Trials.gov (NCT01713192). The registry enrolled all
consecutive patients undergoing cardiac and thoracic aor-
tic surgeries at Seoul National University Hospital from
January 2013 to May 2014. The registry used a combin-
ation of techniques for quality control: standardized dis-
ease definitions and sampling techniques, clear entry on
the data sheet, and review of cases by the managing physi-
cians [14]. The registry included perioperative data with
intraoperative hemodynamics, VOT data, and clinical out-
comes. VOT was performed at designated time points, as
part of the registry. For this study, we included patients
from the registry in whom the VOT was performed.
Patients who may not tolerate the VOT because of, for
example, arm deformities, burns, arteriovenous shunts,
and peripheral vascular disease, were excluded from
analysis.Anesthesia and cardiopulmonary bypass techniques
All patients received standard perioperative care. Routine
monitoring included a bispectral index, cerebral oximetry,
pulmonary artery catheter, and transesophageal echocardi-
ography. Anesthesia was induced with intravenous
midazolam, sufentanil, and vecuronium. Anesthesia was
maintained with continuous infusions of remifentanil
(0.5–1.0 μg/kg per min) and propofol (0.04–0.07 mg/kg
per min), targeting bispectral index values of between 40
and 60. Vecuronium was used as a neuromuscular-
blocking drug. After tracheal intubation, lungs were
ventilated mechanically, and ventilation was adjusted to
maintain an end tidal carbon dioxide tension of 30–35
mm Hg.In on-pump surgeries, a non-pulsatile CPB technique
was used with a membrane oxygenator and cardiotomy
suction. Cardiac protection was achieved by using ante-
grade/retrograde cold blood cardioplegia. Heparin was
administered before CPB or coronary anastomoses and
was neutralized with protamine after discontinuing CPB
or completion of anastomoses. The target activated
clotting times during surgery were more than 500 s for
on-pump cardiac surgery and more than 300 s for off-
pump coronary bypass graft surgery. At the end of sur-
gery, patients were transferred to the intensive care unit
(ICU).
Intraoperative treatment was standardized according to
the routine protocol of our institution. The goal of
hemodynamic management was to maintain a mean arter-
ial pressure of 60-80 mm Hg, a cardiac index of more than
2.0 l/min per m2, and mixed venous oxygen saturation of
more than 60 %. The decision of whether to administer
additional vasopressors or inotropic drugs was taken by
the attending physicians on the basis of the analyzed
hemodynamic status.
Vascular occlusion test
StO2 was measured continuously by using the InSpectra
StO2 tissue oxygenation monitor model 650 (Hutchinson
Technology Inc., Hutchinson, MN, USA). An NIRS sensor
probe was placed on the thenar eminence and maintained
in the same position during all measurements. If the probe
was not attached properly to the thenar eminence, it was
reattached before the VOT. The VOT was performed as
described previously [11]. A conventional pneumatic
blood pressure cuff was placed around the upper arm and
inflated rapidly to 50 mm Hg above systolic blood
pressure and remained inflated until the StO2 decreased
to 40 %. Then, the cuff was deflated rapidly.
The VOT was performed three times per patient: prior
to the induction of anesthesia, at the end of surgery (just
before anesthesia cessation), and on postoperative day 1
(at 7 a.m. the next morning). The StO2 values were re-
corded continuously on the StO2 monitoring device at
2-s intervals and were analyzed by using the InSpectra
Analysis software (version 4.03). The baseline StO2, and
the VOT-derived occlusion and recovery phase parame-
ters were recorded. Occlusion slope was determined by
the decreasing line of the StO2 graph during pneumatic
cuff inflation. The recovery slope was determined by the
increasing line of StO2 graph after pneumatic cuff
deflation.
Study outcomes
The primary endpoint was a composite of major com-
plications that included in-hospital death, myocardial
infarction, acute kidney injury, acute respiratory dis-
tress syndrome, and persistent cardiogenic shock. The
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Myocardial infarction is defined as elevation of cardiac
biomarker values (>10× 99th percentile upper reference
limit) in patients with normal baseline troponin values
(<99th percentile upper reference limit). Additionally, new
pathological Q waves or new left bundle branch block, or
angiographically documented new graft or new native
coronary artery occlusion, or imaging evidence of new loss
of viable myocardium or new regional wall motion abnor-
mality was required [15]. Acute kidney injury was defined
according to the Risk, Injury, Failure, Loss, and End-Stage
Kidney Disease (RIFLE) criteria (Additional file 1: Table S1)
[16]. In the RIFLE criteria, the baseline creatinine level
was defined as the preoperative level. Acute respiratory
distress syndrome was defined according to the Berlin
definition [17]. Persistent cardiogenic shock was defined
as use of inotropic agents, vasopressors, or a mechanical
assist device for more than 72 h.
Secondary endpoints were the ICU and hospital
lengths of stay, defined as the difference in days between
the discharge date and surgery date. Also, the Sequential
Organ Failure Assessment (SOFA) score was calculated
daily until ICU discharge or for a maximum of 7 days.
The initial (0–24 h) and maximum SOFA scores were
calculated.
Statistical analysis
Data were tested for normality by using the Kolmogorov-
Smirnov test. Normally distributed data are expressed as
means (standard deviation), and non-normally distributed
data as median values with interquartile ranges. Continu-
ous variables were compared by using independent t tests
or the Mann-Whitney U test. Categorical variables were
compared by means of chi-squared or Fisher’s exact test.
For tertile data, continuous variables were compared by
analysis of variance (ANOVA) when the distributions were
normal and the variances were equivalent; otherwise, they
were compared by using the Kruskal-Wallis test. Peri-
operative VOT data were compared by repeated-measures
ANOVA with Bonferroni post hoc tests. The study popula-
tion was divided into tertiles according to the recovery
slope on postoperative day 1. The optimal cutoff value for
the recovery slope was calculated by applying a receiver
operating characteristic curve analysis to test all possible
cutoffs that would discriminate composite complications.
A cutoff value was chosen from the point in the receiver
operating characteristic curve that was the closest to the
top left corner of the graph. Associations with clinical out-
comes were assessed by using univariable and multivari-
able linear or logistic regressions. Variables with a P value
of less than 0.2 were entered into a stepwise linear regres-
sion model or a binary logistic analysis with a forward
stepwise condition. Multicollinearity was assessed by com-
puting variance inflation factors for all predictors andremoving all variables with variance inflation factors of
more than 5. A P value of less than 0.05 was considered to
indicate statistical significance. Statistical analyses were
performed by using SPSS software (version 21.0; SPSS
Inc., Chicago, IL, USA).
Results
Patients
From January 2013 to May 2014, 485 patients were en-
rolled in the heart registry. Among them, VOTs could
not be performed in 231 patients and this was due to
the presence of arteriovenous shunts in eight patients
and to a shortage of device or personnel resources in
223 patients. Twenty-two patients were not included in
the analysis because their NIRS data were either missing
or unfit for analysis. Finally, data for 232 patients could
be analyzed (Fig. 1). Demographic data for the patients
are shown in Table 1. Of the 232 patients, 144 under-
went on-pump surgeries and 88 underwent off-pump
surgeries.
In the 232 patients, the rate of composite complica-
tions was 34.9 %. Patients who developed composite
complications had a higher mean age (P = 0.012), higher
rates of congestive heart failure (P = 0.028), and chronic
kidney disease (P = 0.003) than patients who did not
(Table 1). European System for Cardiac Operative Risk
Evaluation II (EuroSCORE II) was significantly higher in
patients with composite complications than in patients
without (P < 0.001). There was no significant difference
in the gender, weight, body mass index, diabetes, hyper-
tension, or stroke between the patients who developed
composite complications and those who did not.
There was no significant difference in the amount of
infused fluid or transfused packed red blood cells during
the surgery between the patients who developed com-
posite complications and those who did not. However,
the duration of surgery was longer in the patients who
developed composite complications than those who did
not (P < 0.001).
Perioperative VOT values
In the overall patients, the recovery slope decreased at the
end of surgery (from 4.5 ± 1.6 to 3.3 ± 1.5, P < 0.001) and
increased on postoperative day 1 (3.7 ± 1.6, P < 0.001).
Repeated-measures ANOVA indicated that the changes in
the recovery slope differed significantly between patients
with and without composite complications (P = 0.003). In
patients without composite complications, the recovery
slope decreased at the end of surgery (from 4.5 ± 1.5 to
3.4 ± 1.4 %/s, P < 0.001) and increased on postoperative
day 1 (4.0 ± 1.5 %/s, P < 0.001). In patients with composite
complications, the recovery slope decreased at the end of
surgery (from 4.3 ± 1.7 to 3.0 ± 1.6 %/s, P < 0.001),
whereas increase in the recovery slope was not evident on
Fig. 1 Study flow chart. VOT vascular occlusion test
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Bonferroni post hoc tests indicated that the recovery slope
was significantly lower in patients with composite compli-
cations compared with patients without composite com-
plications on postoperative day 1 (P = 0.001). The changes
in StO2 (P = 0.277) and occlusion slope (P = 0.487) over
time were not statistically different in patients with or
without composite complications (Table 2).
In patients with CPB, difference of VOT recovery slope
was more prominent on postoperative day 1 (2.9 ± 1.7
versus 4.2 ± 1.6 %/s, P < 0.001, Table 2). In patients with-
out CPB, recovery slope on postoperative day 1 was lower
in patient with composite complications without statistical
significance 1 (3.4 ± 1.6 versus 3.8 ± 1.4 %/s, P = 0.373).
Clinical outcomes and VOT values
At the end of surgery, neither conventional hemodynamic
measurements, such as blood pressure, cardiac index, and
mixed venous saturation, nor VOT values differed signifi-
cantly between patients with and without composite
complications (Table 3). However, on postoperative day 1,
the VOT recovery slope was significantly lower in the pa-
tients with composite complications than in those without
(3.1 ± 1.6 versus 4.0 ± 1.5 %/s, P = 0.001). Hemodynamic
parameters did not differ between groups, with the excep-
tion of central venous pressure, which was higher in the
patients with composite complications. At both time
points, the use of inotropes and vasopressors was higher
in patients with composite complications than in patients
without (Table 3).The study population was divided into tertiles accord-
ing to the recovery slope on postoperative day 1: lowest
tertile of less than 2.9 %/s, middle tertile 2.9–4.3 %/s, and
highest tertile of more than 4.3 %/s (Table 4). There were
significant differences among the tertiles in the ICU
(P = 0.004) and hospital (P = 0.002) length of stay
and the rate of composite complications (P = 0.007;
Fig. 3). A significantly increased risk of composite compli-
cations was observed for the lowest tertile (odds ratio
(OR) = 3.578, 95 % confidence interval (CI) = 1.579–8.106,
P = 0.002) but not in the middle tertile (OR = 1.769, 95 %
CI = 0.759–4.122, P = 0.186) compared with the highest
tertile. Patients in the lowest tertile of the recovery slope
on postoperative day 1 showed 5-day-longer hospital
length of stay than the highest tertile (14 (10.0–29.5)
versus 9 (8.0–15.0), P = 0.002)). Remifentanil and
midazolam usage on postoperative day 1 were not different
between tertiles.
Duration of surgery (r = −0.180, P = 0.017) and lactate
level at the end of surgery (r = −0.177, P = 0.012) were
significantly correlated with recovery slope on postopera-
tive day 1. No significant correlations were found be-
tween postoperative recovery slope and other intraoperative
parameters, such as heart rate, arterial pressure, cardiac
index, and postoperative day 1 troponin I level. EuroSCORE
II (r = −0.205, P = 0.007) was significantly correlated with
recovery slope on postoperative day 1.
Univariable logistic regression analyses were per-
formed, and age, congestive heart failure, chronic kidney
disease, use of the CPB, valvular surgery, EuroSCORE II,
Table 1 Baseline patient, operative characteristics





(n = 232) (n = 81) (n = 151)
Demographic characteristics
Age, years 63 (13) 66 (11) 61 (13) 0.012
Male sex 152 (65.5 %) 53 (65.4 %) 99 (65.6 %) 0.984
Height, cm 163 (9) 163 (10) 163 (8) 0.996
Weight, kg 61 (10) 60 (12) 62 (10) 0.132
Body mass index, kg/m2 23.0 (3.3) 22.5 (4.0) 23.3 (2.8) 0.121
Current smokers 42 (18.1 %) 12 (14.8 %) 30 (19.9 %) 0.341
Coexisting conditions
Diabetes mellitus 61 (26.3 %) 22 (27.2 %) 39 (25.8 %) 0.826
Hypertension 108 (46.6 %) 40 (49.4 %) 68 (45.0 %) 0.527
Stroke 23 (9.9 %) 8 (9.9 %) 15 (9.9 %) 0.989
Dyslipidemia 66 (28.4 %) 26 (32.1 %) 40 (26.5 %) 0.523
Angina 28 (12.1 %) 7 (8.6 %) 21 (13.9 %) 0.241
Myocardiac infarction 8 (3.4 %) 4 (4.9 %) 4 (2.6 %) 0.362
Congestive heart failure 19 (8.2 %) 11 (13.6 %) 8 (5.3 %) 0.028
Liver disease 5 (2.2 %) 2 (2.5 %) 3 (2.0 %) 0.809
Chronic kidney disease 14 (6.1 %) 10 (12.5 %) 4 (2.6 %) 0.003
EuroSCORE II 1.2 (0.8–2.1) 1.7 (1.1–3.2) 1.0 (0.8–1.7) <0.001




50 (21.6 %) 17 (21.0 %) 33 (21.9 %) 0.5878
Beta-blocker 71 (31.0 %) 29 (36.3 %) 42 (28.2 %) 0.209
Calcium channel blocker 69 (29.7 %) 19 (23.5 %) 50 (33.1 %) 0.125
Aspirin 111 (47.8 %) 39 (48.1 %) 72 (47.7 %) 0.946
Insulin 19 (8.2 %) 8 (9.9 %) 11 (7.3 %) 0.493
Intraoperative confounders
Duration of surgery, min 402.3 (112.6) 444.9 (125.7) 379.5 (97.9) <0.001
Duration of CPB, mina 213.3 (88.5) 251.6 (93.1) 181.3 (70.3) <0.001
Crystalloids, ml/kg 14.0 (8.3 - 22.1) 14.9 (10.4 - 23.6) 13.3 (7.3 - 21.6) 0.259
Colloids, ml/kg 11.6 (1.6 - 17.9) 13.6 (0.0 - 19.8) 10.5 (5.6 - 16.1) 0.320
Packed red blood cell transfusion, units 1 (0–3) 1 (0–5) 1 (0–3) 0.053
Type of procedure
Valve 103 (44.4 %) 55 (67.9 %) 48 (31.8 %) <0.001
CABG 96 (41.4 %) 17 (21.0 %) 79 (52.3 %) <0.001
Valve + CABG 8 (3.4 %) 5 (6.2 %) 3 (2.0 %) 0.096
Aortic valve 47 (20.3 %) 20 (24.7 %) 27 (17.9 %) 0.219
Mitral valve 24 (10.3 %) 15 (18.5 %) 9 (6.0 %) 0.003
Other valves 2 (0.9 %) 0 (0 %) 2 (1.3 %) 0.298
Multivalves 22 (9.5 %) 15 (18.5 %) 7 (4.6 %) 0.001
OPCAB 88 (37.9 %) 12 (14.8 %) 76 (50.3 %) <0.001
Aorta surgery 10 (4.3 %) 6 (7.4 %) 4 (2.6 %) 0.089
Other procedures 31 (13.4 %) 8 (9.9 %) 23 (15.2 %) 0.253
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Table 1 Baseline patient, operative characteristics (Continued)
Reoperation 32 (13.8 %) 22 (26.2 %) 10 (6.8 %) <0.001
Data are presented as mean (standard deviation), median (interquartile range), or number (percentage).
EuroSCORE II European System for Cardiac Operative Risk Evaluation II, CPB cardiopulmonary bypass, CABG coronary artery bypass graft surgery, OPCAB off-pump
coronary bypass graft surgery
a69 of 81 (85.2 %) patients with composite complications and 75 of 151 (49.7 %) patients without composite complications were exposed to CPB
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end of surgery, central venous pressure at the end of
surgery, and VOT recovery slope on postoperative day
1 were associated with composite complications (P < 0.05).
Multivariable logistic regression analysis indicated that
age, chronic kidney disease, valvular surgery, and VOT
recovery slope on postoperative day 1 were associated
with the composite complications (Model 1; Additional
file 2: Table S2). Univariable linear regression analyses
showed that age, congestive heart failure, stroke,
chronic kidney disease, use of the CPB, central venous
pressure at the end of surgery, and VOT recovery slope
on postoperative day 1 were associated with hospital
length of stay (P < 0.05). Multivariable analysis indi-
cated that body mass index, chronic kidney disease,
valvular surgery, and VOT recovery slope on postoper-
ative day 1 were associated with hospital length of stay
(Model 1; Additional file 3: Table S3). According to the
receiver operating characteristic curve for the recovery
slope on postoperative day 1, the cutoff value for pre-
dicting composite complications was 3.2 %/s with a
sensitivity of 58.1 % and a specificity of 68.6 % (area
under the curve 0.668, 95 % CI 0.583–0.753, P < 0.001,
Additional file 4: Figure S1).Fig. 2 Changes in vascular occlusion test recovery slope during and after t
indicate significant differences from the previous measurement (P < 0.05).
groups on postoperative day 1Discussion
In this study, the VOT recovery slope decreased at the
end of surgery in cardiac surgery patients. The VOT re-
covery slope recovered on postoperative day 1 in pa-
tients without composite complications but did not in
patient with composite complications. The lowest tertile
of the recovery slope on postoperative 1 showed a three-
to fourfold higher risk of composite complications and
5-day-longer hospital length of stay than the highest
tertile. VOT recovery slope on postoperative day 1 was
independently related with composite complications.
Previous studies have reported that the recovery slope
was associated with clinical outcomes in septic shock pa-
tients [10, 12]. Likewise, in the current study, recovery slope
on postoperative day 1 was associated with composite com-
plications in cardiac surgery patients. Also, hospital length
of stay was longest in lowest tertile of recovery slope. Few
studies have evaluated the relationship between dynamic
StO2 parameters and clinical outcomes in patients under-
going cardiac surgery. In a recent study by Morel et al. [18],
recovery slope was not correlated with ICU length of stay
or SOFA score in cardiac surgery (Additional file 5:
Table S4). However, they enrolled fewer patients (n = 40)
than this study (n = 232). Forty patients might have beenhe surgery. Values are shown as mean (standard deviation). Asterisks
Dagger indicates significant difference in recovery slope between the
Table 2 Vascular occlusion test parameters by the use of cardiopulmonary bypass
Total patients Total patients Patients undergoing CPB Patients not undergoing CPB


































83.3 (6.2) 84.0 (5.8) 0.425 83.8 (5.9) 83.5 (6.2) 0.683 84.2 (5.8) 82.5 (6.6) 0.139 82.6 (6.3) 84.3 (5.7) 0.266
Occlusion
slope, %/min
−9.8 (3.9) −10.3 (5.2) 0.402 −10.1 (5.1) −10.0 (4.2) 0.941 −9.9 (4.1) −9.8 (3.8) 0.825 −10.7 (7.9) −10.3 (4.5) 0.778
Recovery
slope, %/s
4.3 (1.6) 4.7 (1.5) 0.096 4.3 (1.7) 4.5 (1.5) 0.356 4.3 (1.8) 4.3 (1.4) 0.972 4.4 (1.6) 4.7 (1.5) 0.416




77.1 (8.1) 77.6 (7.1) 0.631 79.0 (8.0) 76.4 (7.4) 0.061 78.9 (8.3) 75.5 (7.7) 0.021 79.3 (7.1) 77.2 (7.1) 0.261
Occlusion
slope, %/min
−9.9 (2.6) −9.3 (2.9) 0.103 −9.7 (2.6) −9.6 (2.8) 0.771 −9.7 (2.3) −10.1 (2.8) 0.484 −9.7 (3.6) −9.2 (2.8) 0.551
Recovery
slope, %/s





85.4 (7.7) 86.5 (6.6) 0.319 86.5 (6.6) 85.7 (7.5) 0.513 86.5 (7.3) 84.3 (8.1) 0.229 86.5 (4.4) 86.5 (7.0) 0.991
Occlusion
slope, %/min
−9.0 (2.9) −10.1 (6.8) 0.175 −8.5 (2.7) −10.1 (6.0) 0.066 −8.3 (2.8) −9.6 (2.9) 0.036 −8.9 (2.6) −10.4 (7.4) 0.482
Recovery
slope, %/s
3.6 (1.7) 3.7 (1.4) 0.723 3.1 (1.6) 4.0 (1.5) 0.001 2.9 (1.7) 4.2 (1.6) <0.001 3.4 (1.6) 3.8 (1.4) 0.373

















(n = 81) (n = 151)
At the end of surgery
Heart rate 80 (70–90) 76 (66–84) 0.074
SpO2, % 100 (99–100) 100 (100–100) 0.111
Mean arterial pressure, mm Hg 68 (64–82) 74 (67–78) 0.089
Central venous pressure, mm Hg 10 (6–12) 7 (5–10) 0.002
Cardiac index, l/min per m2 2.5 (0.9) 2.4 (0.6) 0.311
Mixed venous saturation, % 70 (7) 72 (6) 0.051
Temperature, °C 35.8 (0.6) 35.9 (0.6) 0.228
Use of inotropes 32 (39.5 %) 20 (13.2 %) <0.001
Use of vasopressors 35 (43.2 %) 45 (29.8 %) 0.041
Lactate, mmol/l 2.0 (1.2–3.2) 1.5 (1.0–2.1) 0.001
Tissue oxygen saturation, % 78.4 (7.9) 76.4 (8.1) 0.061
VOT occlusion slope, %/min −9.7 (2.6) −9.6 (2.8) 0.771
VOT recovery slope, %/s 3.0 (1.6) 3.4 (1.4) 0.067
First postoperative day
Heart rate 82 (76–92) 78 (72–86) 0.005
SpO2, % 100 (99 – 100) 100 (100–100) 0.669
Mean arterial pressure, mm Hg 74 (68–78) 77 (68–80) 0.310
Central venous pressure, mm Hg 8 (7–10) 7 (5–9) <0.001
Cardiac index, l/min per m2 2.7 (0.6) 2.7 (0.5) 0.857
Temperature, °C 36.7 (0.7) 36.8 (0.6) 0.115
Use of inotropes 60 (74.1 %) 88 (58.7 %) 0.020
Use of vasopressors 27 (33.3 %) 19 (12.6 %) <0.001
Use of midazolam 20 (24.7 %) 7 (4.6 %) <0.001
Use of remifentanil 38 (46.9 %) 29 (19.2 %) <0.001
Tissue oxygen saturation, % 86.5 (6.6) 85.7 (7.5) 0.513
VOT occlusion slope, %/min −8.5 (2.7) −10.1 (6.0) 0.066
VOT recovery slope, %/s 3.1 (1.6) 4.0 (1.5) 0.001
Data are presented as mean (standard deviation), median (interquartile range), or number (percentage)
SpO2 peripheral capillary oxygen saturation, VOT vascular occlusion test
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over, the CPB time of that study was 128 min, less than in
this study (193 ± 104 min). This suggests that the inflam-
matory reaction may have been smaller in the study by
Morel et al.
The VOT recovery slope has been used as an index of
microvascular function, reflecting microvascular reperfu-
sion and reactivity [11, 19, 20]. It was correlated with
peripheral perfusion parameters in critically ill patients
but was independent of the conventional hemodynamic
parameters [9]. Especially in sepsis, endothelial cell func-
tion and microvascular reactivity are altered, with ar-
teriovenous shunting and closed capillaries [12, 21].
Consequently, tissue perfusion could be impaired even withnormal arterial pressure and mixed venous oxygenation
[22, 23]. Previous research has shown that dynamic StO2
parameters were superior to conventional parameters in
predicting prognosis in patients with septic [10, 19]. This is
consistent with our results, in which the VOT recovery
slope was associated with composite complications whereas
conventional hemodynamic parameters, such as arterial
pressure or cardiac index, did not show an association on
postoperative day 1 (Table 3). However, there were group
differences in the use of inotropes or vasopressors.
These results can be explained by the fact that arterial
pressure and the cardiac index are usually the targets of
hemodynamic management. Consequently, there were
no differences in these variables, but there were
Table 4 Clinical outcomes by the tertile according to the recovery slope on postoperative day 1
Totala Totalb Lowest tertile Middle tertile Highest tertile P value
(n = 232) (n = 173) (n = 58) (n = 57) (n = 58)
Composite complications 81 (34.9 %) 58 (33.5 %) 28 (48.3 %) 18 (31.6 %) 12 (20.7 %) 0.007
In-hospital mortality 6 (2.6 %) 5 (2.9 %) 2 (3.4 %) 2 (3.5 %) 1 (1.7 %) 0.809
Myocardial infarction 2 (0.9 %) 2 (1.2 %) 0 (0.0 %) 1 (1.8 %) 1 (1.7 %) 0.600
Acute kidney injury
RIFLE Risk category 56 (24.1 %) 38 (22.0 %) 16 (27.6 %) 13 (22.8 %) 9 (15.5 %) 0.287
RIFLE Injury category 28 (12.1 %) 20 (11.6 %) 10 (17.2 %) 6 (10.5 %) 4 (6.9 %) 0.210
RIFLE Failure category 25 (10.8 %) 20 (11.6 %) 12 (20.7 %) 5 (8.8 %) 3 (5.2 %) 0.024
Renal replacement therapy 15 (6.5 %) 14 (8.1 %) 8 (13.8 %) 4 (7.0 %) 2 (3.4 %) 0.116
Acute respiratory distress syndrome 7 (3.0 %) 7 (4.0 %) 3 (5.2 %) 3 (5.3 %) 1 (1.7 %) 0.545
Persistent cardiogenic shock 32 (13.8 %) 24 (13.9 %) 15 (25.9 %) 7 (12.3 %) 2 (3.4 %) 0.002
Initial SOFA 9 (8–11) 5 (3–7) 6 (3–9) 5 (3–8) 3 (4–9) 0.005
Maximum SOFA 12 (10–14) 6 (4–9) 7 (4–10) 7 (4–9) 5 (3–7) 0.001
Mechanical ventilation-free days, days 1 to 28 27.2 (27.0–27.4) 27.2 (27.0–27.4) 27.1 (26.2–27.3) 27.3 (27.0–27.4) 27.3 (27.2–27.5) 0.004
Intensive care unit length of stay, days 4 (3–6) 4 (3–6) 5 (3–8) 3 (2–6) 3 (2–5) 0.004
Hospital length of stay, days 11 (11–18) 11 (8–18) 14 (10–29) 12 (9–17) 9 (8–15) 0.002
Data are presented as number (percentage) or median (interquartile range)
RIFLE Risk, Injury, Failure, Loss and End-stage Renal Disease, SOFA Sequential Organ Failure Assessment
aTotal patients with composite complications data









Fig. 3 a Hospital length of stay. b Rate of composite complications stratified by tertiles of recovery slope on postoperative day 1. The boxes
indicate the first quartile (bottom line), the median (central line) and the third quartile (upper line). The whiskers represent whiskers represent 10
%/90 % quantiles. Lowest tertile < 2.9 %/s, middle tertile 2.9–4.3 %/s, and highest tertile > 4.3 %/s
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tropes or vasopressors to reach the target blood pres-
sure or cardiac index.
Cardiac surgery provokes a vigorous inflammatory re-
sponse and can induce systemic inflammatory response
syndrome (SIRS) [13]. Surgical trauma, blood loss, trans-
fusion, hypothermia, hypoperfusion, and CPB may be
causes of the inflammatory reaction. The vascular endo-
thelium plays a pivotal role in this inflammatory reaction
and microcirculatory derangement during cardiac sur-
gery [13]. As SIRS impairs the microcirculation and
ultimately can lead to multiorgan failure, we hypothe-
sized and showed in this study that a perioperative de-
crease in microcirculatory function may be associated
with adverse clinical outcomes in cardiac surgery pa-
tients. Several studies have shown that VOT recovery
slope decreases during CPB but returns to the baseline
value postoperatively [18, 24]. This perioperative change
in the recovery slope was also seen in the present study.
Moreover, in the present study, the impaired VOT re-
covery slope on postoperative day 1 was independently
related to composite complications, suggesting that
microvascular reactivity is impaired during cardiac sur-
gery and furthermore that this is associated with poor
clinical outcomes, as observed in sepsis. A decreased re-
covery slope represents a deficit in the capacity to re-
cruit microvessels in response to a hypoxic stimulus,
which might be associated with local tissue inflamma-
tion, impaired oxygen extraction, and ultimately organ
dysfunction after cardiac surgery [10, 12].
The effects of CPB on microcirculatory alterations
and inflammation are well known [8, 13, 24]. In this
study, we compared the patient data according to the
use of CPB (Table 2). In patients with CPB, thedifference in the recovery slope between patients with
and without complications was more prominent on
postoperative day 1. However, the VOT variables did
not differ in patients with and without CPB. In
addition, the use of CPB did not show a significant as-
sociation with composite complications in the multivar-
iable model. A better evaluation of the effect of CPB
might be achieved by controlling possible confounding
factors such as the type of surgery, duration of CPB,
and temperature.
Our results demonstrated that postoperative day 1 re-
covery slope was related to duration of surgery and lactate
level at the end of surgery. Hyperlactemia, a well-known
marker of tissue hypoperfusion, is frequently observed
during and after cardiac surgery [25]. High lactate level at
the end of surgery may be the result of intraoperative oc-
cult tissue hypoperfusion and associated with postopera-
tive complications [26]. Likewise, in the present study,
lactate level was higher in patients with composite compli-
cations than in patients without (Table 3).
The VOT occlusion slope reflects oxygen metabolism
in the tissue; thus, a low occlusion slope indicates im-
paired regional perfusion distribution, lower metabolic
rate, or impairment in oxygen utilization by mitochon-
dria [11, 27]. Several studies have reported that the oc-
clusion slope is lower in septic shock patients [28, 29],
and the prehospital occlusion slope was associated with
the need for lifesaving intervention in trauma patients
[27]. In the present study, the occlusion slope over time
did not differ significantly between patients with and
without composite complications. However, a decreasing
trend was seen in patients with composite complications,
and the occlusion slope on postoperative day 1 was lower
in patients with composite complications, although this
Kim et al. Critical Care  (2015) 19:316 Page 11 of 12lacked statistical significance (−8.5 ± 2.7 versus −10.1 ±
6.0 %/min, P = 0.066, Table 2).
VOT-derived occlusion and recovery slopes provide
semicontinuous measurements of microvascular reactivity,
which may be an important target for therapy in surgery
[10, 11]. Pathological changes in tissue microcircula-
tion reactivity, as indicated by a low recovery slope,
may provide information regarding the prognosis in
patients undergoing cardiac surgery. However, to date,
what should be done for patients who show impaired
microcirculatory reactivity is unknown. Further re-
search is needed on this topic.
This study had several limitations. First, it was a
single-center study and enrolled a heterogeneous cardiac
surgery population. Moreover, in our center, coronary
artery bypass graft surgery is routinely performed with-
out CPB; indeed, only eight coronary artery bypass graft
surgery cases were performed with CPB. Thus, our re-
sults do not reflect the on-pump coronary artery bypass
graft surgery scenario. Second, the VOT itself has not
been standardized with regard to the site of measure-
ment, ischemic threshold, or time interval between tests
[30]. Also, the VOT occlusion or recovery slope does
not always show clear linearity and this is due to tech-
nical issues in sampling or voluntary thenar muscle ac-
tivity [11]. Third, VOT was not performed serially in the
ICU. Thus, the question of when the recovery slope is
restored completely to preoperative levels was not inves-
tigated in the current study. Fourth, use of vasopressors
might confound VOT results. In this study, vasopressors
were used more frequently in patients with composite
complications than in those without. Although vaso-
pressors are used to increase mean arterial pressure
and perfusion pressure, high-dose vasopressor may
cause various peripheral hypoperfusion conditions [31].
In spite of more frequent use of inotropics and vaso-
pressors, cardiac output and blood pressure were not
different between the patients with and those without
complications. It may suggest that the use of inotropics
and vasopressors may improve hemodynamic status but
not clinical outcomes. Fifth, in this study, anesthesia
was maintained with remifentanil-propofol continuous
infusion, which may increase muscle blood flow [32].
Thus, the results may differ with inhalational agent-
based anesthesia.Conclusions
Microvascular reactivity, assessed by VOT recovery
slope, decreases during cardiac surgery and recovers on
postoperative day 1. Patients with lower recovery slopes
on postoperative day 1 showed higher complication
rates and longer hospital length of stay. Postoperativerestoration of microvascular reactivity is related to clin-
ical outcomes in cardiac surgery patients.Key message
 Microvascular reactivity, assessed by VOT recovery
slope, decreased during cardiac surgery.
 Microvascular reactivity largely recovered on
postoperative day 1 in patients without composite
complications, but this restoration was attenuated in
patients with composite complications.
 The lowest tertile of the recovery slope on
postoperative 1 showed a higher composite
complication rate and longer hospital length of stay
than the highest tertile.
 Microvascular reactivity on postoperative day 1 was
independently related with composite complications.Additional files
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